IGNITE Canada: Developing Pod System V15000 with Smart Screen Upgrade

Sep.20.2024
IGNITE Canada: Developing Pod System V15000 with Smart Screen Upgrade
Canadian brand IGNITE drew attention at the Dortmund tobacco exhibition with its innovative products from September 19-21.

At the Dortmund Tobacco Expo from September 19 to 21, the Canadian brand IGNITE attracted a lot of attention with its innovative products. Lisa Kabatsky, Global Operations Manager of IGNITE International Brands, told 2Firsts that at this exhibition, IGNITE showcased two disposable products, v8000 and v15000. The v8000 was launched last year, while the v15000 was just released a few months ago and had not yet been introduced to the German market.

IGNITE Canada: Developing Pod System V15000 with Smart Screen Upgrade

Lisa Kabatsky, Global Operations Manager of IGNITE International Brand, | Image source: 2Firsts

 

IGNITE Canada: Developing Pod System V15000 with Smart Screen Upgrade

IGNITE has released disposable products v8000 and v15000. | Image source: 2Firsts.

 

IGNITE Canada: Developing Pod System V15000 with Smart Screen Upgrade

IGNITEdisposable product v8000 | Image source: 2Firsts

 

Due to strict regulations in the local market, IGNITE is focusing on promoting low-nicotine products in the German market, while simultaneously developing switchable products that comply with regulations. Lisa Kabatsky stated that there is high demand for ice-flavored products in the German market, with no strong preference for other flavors and no noticeable trends.

 

IGNITE has expressed their views on the future trends of e-cigarettes to 2Firsts. Lisa Kabatsky believes that smart e-cigarettes are the way of the future, with the company upgrading their v15000 model and planning to equip it with a smart side screen to cater to the market's demand for smart products. Additionally, Lisa Kabatsky stated that IGNITE is also producing n-in-1 and 2+10 products, expected to be launched in the UK and EU regions, further expanding the company's market presence.

 

Lisa Kabatsky criticizes the regulatory policies issued by the United States FDA, stating that they have a negative impact on industry innovation and corporate development.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
At the inaugural AFN, Dr. Rohan Sequeira and Dr. Alex Wodak emphasized that THR offers a science-based approach to reduce smoking-related harm—not merely as an alternative to cessation. They urged policymakers across Asia to reassess tobacco control and include non-combustible products in public health strategies. This article outlines the scientific foundation of THR, its regional challenges, and growth momentum.2Firsts provided in-depth coverage of the forum.
Sep.09
Shine at InterTabac 2025: Choose 2FIRSTS Exhibition Brand Promotion Package to Make Your Brand Seen Globally!
Shine at InterTabac 2025: Choose 2FIRSTS Exhibition Brand Promotion Package to Make Your Brand Seen Globally!
2FIRSTS will provide enterprises and brands with exclusive brand promotion resource packages, covering pre-exhibition warm-up, on-site interviews, and global release.
Aug.06
A recent study in the UK has found that teenagers who vape are three times more likely to become smokers, sparking a heated public debate
A recent study in the UK has found that teenagers who vape are three times more likely to become smokers, sparking a heated public debate
A UK study reveals children who frequently use e-cigarettes are three times more likely to become smokers later in life.
Aug.20 by 2FIRSTS.ai
UK MHRA Reports 193 e-cigarette SKUs, Including Brands VAPORESSO, IJOY, ALD, ASPIRE, HAYATI, SMOK
UK MHRA Reports 193 e-cigarette SKUs, Including Brands VAPORESSO, IJOY, ALD, ASPIRE, HAYATI, SMOK
MHRA database reveals 193 e-cigarette SKUs in the UK market from brands like VAPORESSO, IJOY, ALD, and SMOK.
Aug.28 by 2FIRSTS.ai
Greentank Technologies Appoints Chris Gemmell as Chief Product and Innovation Officer
Greentank Technologies Appoints Chris Gemmell as Chief Product and Innovation Officer
Greentank Technologies appoints Chris Gemmell as Chief Product & Innovation Officer, bringing extensive experience from tobacco industry.
Sep.04 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai